A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2017.05.009
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2017
Authors
Publisher
Elsevier BV